BPC-157 Benefits as Shown in Research
Share
BPC-157 is a stable gastric pentadecapeptide that has been extensively studied for its potential therapeutic benefits, particularly in the context of gastrointestinal and musculoskeletal healing. Here are some of the key benefits supported by the medical literature:
1. Gastrointestinal Protection and Healing: BPC-157 has demonstrated significant protective and healing effects on the gastrointestinal (GI) tract. It has been shown to promote the healing of various GI lesions, including those induced by NSAIDs, alcohol, and other ulcerogenic agents. This peptide enhances mucosal integrity and exhibits strong anti-ulcer properties.[1-3]
2. Wound Healing: BPC-157 has been found to accelerate the healing of various types of wounds, including skin incisions, excisions, burns, and diabetic ulcers. It promotes angiogenesis, which is crucial for wound healing, and helps in the resolution of vessel constriction and clot formation.[4-5]
3. Musculoskeletal Healing: BPC-157 has shown promise in the healing of musculoskeletal injuries, including those affecting tendons, ligaments, and muscles. It has been effective in both traumatic and systemic injury models, suggesting its potential utility in treating hypovascular and hypocellular tissues.[5]
4. Neuroprotective Effects: BPC-157 has demonstrated neuroprotective properties, including the protection of somatosensory neurons and the promotion of peripheral nerve regeneration. It has also been shown to counteract the progression of traumatic brain injury and spinal cord compression.[6]
5. Cardiovascular Benefits: BPC-157 has been reported to counteract heart failure, arrhythmias, and thrombosis. It helps in the recovery of smooth muscle function and has a beneficial impact on vascular and multiorgan failure associated with major vessel occlusion.[7]
6. Anti-inflammatory and Cytoprotective Effects: BPC-157 exhibits strong anti-inflammatory properties and acts as a cytoprotective agent. It has been shown to counteract the toxic effects of NSAIDs and other harmful agents on the GI tract, liver, and brain.[8]
7. Modulation of Neurotransmitter Systems: BPC-157 interacts with various neurotransmitter systems, including dopamine, serotonin, and GABA. It has been shown to have anxiolytic, anticonvulsive, and antidepressant effects, and to counteract symptoms in models of schizophrenia.[7][9]
8. Systemic Healing and Organ Protection: BPC-157 has a broad range of organoprotective effects, including the healing of extragastrointestinal tissues such as skin, tendons, ligaments, muscles, bones, nerves, and the cornea. It also counteracts complications related to the NO-system, such as hypertension and prolonged bleeding.[1]
In summary, BPC-157 offers a wide array of therapeutic benefits, particularly in the healing of gastrointestinal and musculoskeletal injuries, neuroprotection, cardiovascular health, and modulation of neurotransmitter systems. These effects are supported by various studies, although most of the research has been conducted in animal models, and further clinical trials are needed to confirm its efficacy and safety in humans.
1. Stress in Gastrointestinal Tract and Stable Gastric Pentadecapeptide BPC 157. Finally, Do We Have a Solution?. Sikiric P, Seiwerth S, Rucman R, et al. Current Pharmaceutical Design. 2017;23(27):4012-4028. doi:10.2174/1381612823666170220163219.
2. Stable Gastric Pentadecapeptide BPC 157: Novel Therapy in Gastrointestinal Tract.
Sikiric P, Seiwerth S, Rucman R, et al. Current Pharmaceutical Design. 2011;17(16):1612-32. doi:10.2174/138161211796196954.
3. Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing. Sikiric P, Rucman R, Turkovic B, et al.
Current Pharmaceutical Design. 2018;24(18):1990-2001. doi:10.2174/1381612824666180608101119.
4. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.
Seiwerth S, Milavic M, Vukojevic J, et al. Frontiers in Pharmacology. 2021;12:627533. doi:10.3389/fphar.2021.627533.
5. Gastric Pentadecapeptide Body Protection Compound BPC 157 and Its Role in Accelerating Musculoskeletal Soft Tissue Healing.
Gwyer D, Wragg NM, Wilson SL. Cell and Tissue Research. 2019;377(2):153-159. doi:10.1007/s00441-019-03016-8
6. Brain-Gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications. Sikiric P, Seiwerth S, Rucman R, et al. Current Neuropharmacology. 2016;14(8):857-865. doi:10.2174/1570159x13666160502153022.
7. Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis Function. Sikiric P, Gojkovic S, Krezic I, et al. Pharmaceuticals (Basel, Switzerland). 2023;16(5):676. doi:10.3390/ph16050676.
8. Toxicity by NSAIDs. Counteraction by Stable Gastric Pentadecapeptide BPC 157.
Sikiric P, Seiwerth S, Rucman R, et al. Current Pharmaceutical Design. 2013;19(1):76-83. doi:10.2174/13816128130111.
9. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations With Neurotransmitter Activity. Sikiric P, Boban Blagaic A, Strbe S, et al. Pharmaceuticals (Basel, Switzerland). 2024;17(4):461. doi:10.3390/ph17040461.